Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Mar;2(1):69-84.
doi: 10.1007/s40674-016-0038-7. Epub 2016 Feb 5.

Scleroderma Mimickers

Nadia D Morgan  1 , Laura K Hummers  1
Affiliations

Scleroderma Mimickers

Nadia D Morgan et al. Curr Treatm Opt Rheumatol. 2016 Mar.

Abstract

Cutaneous fibrosing disorders encompass a diverse array of diseases united by the presence of varying degrees of dermal sclerosis. The quality and distribution of skin involvement, presence or absence of systemic complications and unique associated laboratory abnormalities often help to distinguish between these diseases. It is imperative that an effort is made to accurately differentiate between scleroderma and its mimics, in order to guide long-term management and facilitate implementation of the appropriate treatment modality where indicated.

Keywords: Eosinophilic fasciitis; Morphea; Nephrogenic systemic fibrosis; Scleredema; Scleroderma; Scleromyxedema; Systemic sclerosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest Nadia D. Morgan declares that she has no conflict of interest. Laura K. Hummers declares that she has no conflict of interest.

Figures

Figure 1
Figure 1
a. Characteristic subcutaneous nodules, depicted in the hand of a patient with scleromyxedema. b. Pansclerotic morphea involving the feet.
See this image and copyright information in PMC

References

    1. Mayes MD, Lacey JV, Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis and rheumatism. 2003;48(8):2246–55. - PubMed
    1. Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am. 2003;29(2):239–54. - PubMed
    1. Wollheim FA. Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford, England) 2005;44(10):1212–6. - PubMed
    1. Pasero G, Marson P. Hippocrates and rheumatology. Clinical and experimental rheumatology. 2004;22(6):687–9. - PubMed
    1. A. B. Ueber Skleroedem. Berl Klin Wochenschr. 1902;(39):955.

LinkOut - more resources